It functions like a toggle that can eliminate the pain.
Diabetic neuropathy is a condition primarily impacting the nerves linked to the feet. In the United States, around 34.2 million people, or 10.5% of the population, have diabetes, and it is estimated that 50% of these individuals will experience diabetic peripheral neuropathy (DPN).
The FDA’s approval of spinal cord stimulation (SCS) for treating peripheral neuropathy pain marks an important advancement in managing chronic neuropathic pain. SCS provides a hopeful option for patients who have not found relief with conventional treatments, potentially offering sustained pain relief and a better quality of life.
Several clinical studies have demonstrated the efficacy of SCS in managing peripheral neuropathy pain
Peripheral neuropathy is a common neurological disorder characterized by damage to the peripheral nerves, leading to various sensory, motor, and autonomic dysfunctions.
Spinal cord stimulation is a neuromodulation technique that involves the delivery of electrical impulses to the spinal cord to interrupt or mask pain signals before they reach the brain.
Spinal cord stimulation (SCS) is a neuromodulation method that sends electrical impulses to the spinal cord to block or alter pain signals before they reach the brain. Recently, the application of SCS for managing peripheral neuropathy pain has gained more attention, with multiple studies showing positive results in pain relief, enhanced functionality, and increased patient satisfaction.
Peripheral neuropathy is a challenging condition resulting from damage to the peripheral nerves, causing persistent pain that greatly affects the lives of those suffering from it. Conventional treatments like medication and physical therapy often fall short of providing sufficient relief. Spinal cord stimulation (SCS) has become a promising treatment alternative for controlling neuropathic pain.
Dr. Morar is a board-certified Interventional Radiologist trained at the Cleveland Clinic. He has been in clinical practice since 2005 and has performed over 30,000 Interventional radiology procedures. He has a special interest in embolization procedures which require closing down blood vessels from the inside using x-ray guidance. He has performed well over 5000 of these procedures which has included treating uterine, fibroids, hemorrhoids and obesity for weight loss amongst others. He was one of the first physicians in the nation to publish research on hemorrhoidal artery embolization as early as 2005.
As a native of Ohio, Dr. Morar has owned and operated his own outpatient Interventional Radiology practice in Cincinnati and Dayton for over 18 years. He now enjoys teaching radiology residence and fellows as part-time faculty at the University of Cincinnati and also provides Interventional radiology services at Mercy Hospital in Youngestown Ohio.
In his spare time, Dr. Morar enjoys healthcare philanthropy work, which has largely involved building healthcare infrastructure, and Interventional radiology services in rural India.
He is also a lifetime member of the Society Interventional Radiology serving on several educational committees promoting the awareness of Interventional Radiology treatment options.
https://link.springer.com/article/10.1007/s00270-003-4092-9#citeas